Nintedanib in idiopathic pulmonary fibrosis.
H.V. Woodcock, Toby M. Maher
págs. 345-356
Nintedanib, a novel triple angiokinase inhibitor for the treatment of non-small cell lung cancer.
Tomas S. Noonan, K. M. Wong, Antonio Jimeno
págs. 357-366
Omalizumab is efficacious for management of recalcitrant, antihistamine-resistant chronic urticaria.
D.M. Lang
págs. 367-374
American Psychiatric Association –168th Annual Meeting (May 16-20, 2015 – Toronto, Canada).
T. W. A. Kibble
págs. 375-382
American Diabetes Association – 75th Scientific Sessions (June 5-9, 2015 – Boston, Massachusetts, USA).
M. Glessner
págs. 383-386
The European League Against Rheumatism (EULAR) –16th Annual European Congress (June 10-13, 2015 – Rome, Italy).
M. Olle
págs. 387-392
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: